Exhibitor Product Theater - Long-term Safety and Efficacy Data for a Chronic Hepatitis B (CHB) Treatment Option

Robert S. Brown, Jr., MD, MPH, FACG

Sponsored by Gilead Sciences, Inc.

During this presentation, we will discuss the prevalence of chronic hepatitis B, the burden of disease, and the current treatment guidelines. We will also share the latest updated efficacy and safety data for a CHB treatment.

Open to all ACG 2022 attendees, industry-sponsored Product Theater provide additional educational opportunities. These programs are independent of the ACG 2022 Annual Scientific Meeting and Postgraduate Course programs. No CME is provided for Exhibit Product Theater presentations.